Company News

Bloom Energy posts GAAP EPS beat at $0.45 vs $0.30 estimate, but adjusted EPS of -$0.30 and weak Q1 guidance…

Gregory T. Lucier purchased 15,000 shares at $12.445, deploying $186,675 to increase his stake by 30% to 65,000 shares.

URBN executives forfeited 30,862 shares worth $2.03M for tax withholding on March 9, led by Global CEO Sheila Harrington's 3,959-share…

SCI President forfeited 3,300 shares at $81.42 for tax obligations, part of a four-executive cluster totaling $675,053 in routine equity…

TTMI posts Q4 EPS of $0.70 vs $0.68 estimate, revenue reaches $774.3M as shares jump 10.1% on fourth straight earnings…

Legend Biotech posts $0.01 adjusted EPS in Q4 2025, turning profitable on 64% revenue growth to $306.3M as commercial momentum…

Cullinan Therapeutics posts $0.73 per share loss in Q4 2025, matching year-ago results as the pre-revenue biotech maintains clinical development…

Apyx Medical narrows Q4 loss to $0.06 per share as revenue surges 34.8% year-over-year to $19.2 million, with fiscal 2026…

Prelude Therapeutics reports Q4 loss of $1.29/share, 616.7% wider than expected, despite revenue jumping to $12.1M from $6.5M sequentially.

Opus Genetics posts $0.80 Q4 loss as revenue surges 230% year-over-year to $14.2M on collaboration activity.